drugset / Trial / NCT00713921
Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients
NaSingle-groupOpen-labelDiagnostic
Summary
Develop and quantify methods for evaluating bladder dysfunction in diabetes and stroke
Timeline
- Start
- 2009-09-15
- Primary completion
- 2014-01-17
- Completion
- 2014-01-17
Outcome
Outcome not reported
Stopped (Enrollment): “Lack of enrollment and loss of funding”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fesoterodine | Other / unclassified | 4 mg | Oral |
| Subject | Fesoterodine | Other / unclassified | 8 mg | Oral |